The SC however, restrained the NGT from taking any punitive action against the directors of the company, regarding the deposition of Rs 100 crore, after Volkswagen informed that it had complied with the orders and deposited the amount with the CPCB.
The Nikkei newspaper reported on Sunday that a French government delegation had informed Tokyo that it would seek an integration of Renault SA and Nissan, most likely under the umbrella of a single holding company.
The company’s flagship IT services revenues grew 2 per cent to Rs 14,665 crore. In US dollar terms, the IT services revenues stood at $2,046.5 million, which was at the middle of the guidance on actual currency basis.
In a stock exchange filing, Sun Pharma said, “the company has not received the alleged 172–page whistle blower complaint and therefore we are not privy to the contents of the document being referred in the said media article.
The complaint, sent to SEBI, is reportedly the second in over a month. The whistleblower alleges that Aditya Medisales Ltd had transactions with Suraksha Realty, controlled by Sun Pharma's co-promoter, Sudhir Valia.